Eli Lilly and Co
NYSE:LLY
Eli Lilly and Co
NYSE:LLY
Price:
770 USD
-0.15%
Market Closed
Updated:
May 18, 2024
Eli Lilly and Co
Research & Development
|
Eli Lilly and Co
Research & Development Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
ZTS
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Eli Lilly and Co
NYSE:LLY
|
Research & Development
-$9.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-6%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Research & Development
-$15.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Research & Development
-$9.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Pfizer Inc
NYSE:PFE
|
Research & Development
-$10.6B
|
CAGR 3-Years
-74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Research & Development
-$29.5B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-15%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Research & Development
-$634m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-5%
|
See Also
What is Eli Lilly and Co's Research & Development?
Research & Development
-9.9B
USD
-9.9B
USD
Based on the financial report for Mar 31, 2024, Eli Lilly and Co's Research & Development amounts to -9.9B USD.
What is Eli Lilly and Co's Research & Development growth rate?
Research & Development CAGR 10Y
-6%
-6%
Over the last year, the Research & Development growth was -30%. The average annual Research & Development growth rates for Eli Lilly and Co have been -16% over the past three years , -14% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
